StackTerminal.Health

BETA

GHRP-2

GHRP-2 is a synthetic hexapeptide ghrelin receptor agonist that produces a potent and reliable GH pulse, and has been used in research settings as a diagnostic provocative test for GH secretory capacity. Beyond GH release, GHRP-2 meaningfully elevates cortisol, prolactin, and ACTH — particularly at higher doses — a broader neuroendocrine activation profile that limits its appeal relative to more selective GHRPs like ipamorelin. Human pharmacokinetic and pharmacodynamic data are among the most well-characterized of any research GHRP, with studies in GH deficiency, cachexia, and critical illness contexts. Wellness use requires awareness of the cortisol and prolactin co-stimulation, and no regulatory approval exists outside of diagnostic and investigational research applications.

growth hormonerecoverybody compositionappetitepeptide

Evidence last reviewed: 19 Apr 2026

Research / clinical compound

Not a routine supplement — not recommended for self-directed use.

Information here is educational only, not a recommendation to use. See our Safety page.

CertiPep

Verify this peptide on CertiPep

certipep.ch — anonymous purity & characterization service

Evidence
5 records
5 recordsBest grade:Moderate
Biomarkers
Growth HormoneCortisol

Evidence is from research or clinical settings — does not imply safety outside supervised contexts.

GHRP-2 has moderate evidence supporting its effectiveness in stimulating GH secretion across various populations, including children and adults with GH deficiencies. However, its impact on cortisol and prolactin may limit its appeal for broader use.

GH secretion
Normal adults · RCT
Moderate
GH secretion
Children with GH insufficiency and idiopathic short stature · RCT
Moderate

GHRP-2 increased GH secretion in children with GH insufficiency and idiopathic short stature.

Dose in study: 0 mg(trial dose)Form: Intravenous
Cortisol secretion
Healthy non-obese male volunteers · RCT
Moderate

GHRP-2 stimulated cortisol secretion, influenced by secretagogue type and sex-steroid milieu.

Dose in study: 0 mg(trial dose)
GH secretion
Young men with experimentally induced hypogonadism · RCT
Moderate

GHRP-2 maintained efficacy in stimulating GH release despite hypogonadism.

Dose in study: 0 mg(trial dose)
GH secretion
Children with GH insufficiency and idiopathic short stature · RCT
Moderate
Stacks containing GHRP-2
Explore all →
This compound is not included in any public supplement stacks.
Community Insights
Forms & usage
Intravenous
Commonly used in clinical settings for precise dosing.
Subcutaneous
Preferred for self-administration due to ease of use.
My notes
Sign in to keep a private note on GHRP-2.